French international pioneer in respiratory health.

Based in Nice, this excellence center aims to develop innovative approaches for diagnosing, treating and preventing respiratory diseases.

Our Upcoming Events

Exposome 2026 Congress in Nice: addiction, environment, and respiratory health at the heart of a scientific event chaired by Prof. Paul Hofman.
Events
Exposome Congress 2026: understanding the impact of addictions on respiratory health
04/08/2026
On Wednesday, April 8, 2026, in Nice, IHU RespirERA will host the 3rd edition of the Exposome Congress...
International congress in Nice exploring the impact of AI in thoracic pathology and its clinical applications in respiratory health.
Events
AI in the Next World of Thoracic Pathology
10/06/2026
- 10/07/2026
L’Intelligence Artificielle au service du diagnostic en pathologie thoracique L’IHU RespirERA organise à Nice (hôtel...

Our news

Le Pr Paul Hofman présentera le projet ETOP Lungscope à l’ELCC 2026, un programme européen pour mieux comprendre le cancer du poumon.
Congress
ELCC 2026: Prof. Paul Hofman presents the ETOP Lungscope project
Prof. Paul Hofman, Director of IHU RespirERA, will take part in the European Lung Cancer Congress (ELCC) 2026...
Stage III lung cancer: a European consensus defines which cases are operable and improves clinical trial consistency.
Publication
Stage III lung cancer: a European consensus to better define operable tumors
A group of European experts has published a consensus document to better define which stage III lung cancers can be operated on...
Liquid biopsy: a blood test used to analyze circulating tumor cells in the body, without the need for a traditional biopsy.
Congress
Liquid biopsy: Prof. Paul Hofman speaks at the 2026 Scientific Day
On June 4, 2026, Gustave Roussy will host in Paris a scientific day dedicated to liquid biopsy...

Our missions

IHU RespirERA is committed to five key missions to explore the impact of aging and the environment on respiratory health, placing the patient at the heart of its projects.
Understand

the mechanisms of respiratory diseases to better address them.

Prevent

by identifying environmental risk factors and developing effective prevention strategies.

Treat

by creating personalized treatments tailored to each patient’s specific needs.

Innovate

by integrating new technologies, including artificial intelligence and robotics, to enhance diagnosis and care.

Educate & Train

healthcare professionals and the general public on emerging technologies and best practices.

Our strategy

IHU RespirERA is built on a synergy between researchers, clinicians, patient associations, and industry partners, fostering effective collaboration to understand and treat respiratory diseases. This holistic approach considers all aspects of these pathologies, from biological factors to environmental impacts, to develop comprehensive and innovative solutions. The Provence-Alpes-Côte d’Azur region, significantly affected by pollution and an aging population, serves as our "living laboratory", enabling us to develop real-world solutions tailored to environmental and health challenges.

Our projects

Discover our flagship projects that need your support!

Lung Cancer Screening
IHU RespirERA is a leading actor in the deployment of lung cancer screening in France.

Support us

to give new life to research!

By supporting IHU RespirERA, you are directly contributing to the funding of our innovative projects across all areas of respiratory health.

Every donation is a breath of fresh air for research.

Our founding members

Our institutional support

Supported by the ANR through France 2030: ANR-23-IAHU-0007